ci 988 has been researched along with n-succinimidyl-3-(4-hydroxyphenyl)propionate in 1 studies
| Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (n-succinimidyl-3-(4-hydroxyphenyl)propionate) | Trials (n-succinimidyl-3-(4-hydroxyphenyl)propionate) | Recent Studies (post-2010) (n-succinimidyl-3-(4-hydroxyphenyl)propionate) |
|---|---|---|---|---|---|
| 147 | 8 | 14 | 133 | 0 | 13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hinks, GL; Hughes, J; Poat, JA | 1 |
1 other study(ies) available for ci 988 and n-succinimidyl-3-(4-hydroxyphenyl)propionate
| Article | Year |
|---|---|
Changes in hypothalamic cholecystokininA and cholecystokininB receptor subtypes and associated neuropeptide expression in response to salt-stress in the rat and mouse.
Topics: Animals; Autoradiography; Benzodiazepinones; Cholecystokinin; Devazepide; Hormone Antagonists; Hypothalamus; In Situ Hybridization; Indoles; Male; Meglumine; Mice; Mice, Inbred Strains; Neuronal Plasticity; Neuropeptides; Oligonucleotide Probes; Osmolar Concentration; Rats; Rats, Wistar; Receptors, Cholecystokinin; RNA, Messenger; Saline Solution, Hypertonic; Succinimides | 1995 |